HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹533 Cr | ₹643 Cr | ₹590 Cr | ₹432 Cr | ₹379 Cr |
What is the latest Total Non-Current Liabilities ratio of HIKAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹533 Cr |
| Mar2024 | ₹643 Cr |
| Mar2023 | ₹590 Cr |
| Mar2022 | ₹432 Cr |
| Mar2021 | ₹379 Cr |
How is Total Non-Current Liabilities of HIKAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹533 Cr | -17.09 | |
| Mar2024 | ₹643 Cr | 8.90 | |
| Mar2023 | ₹590 Cr | 36.71 | |
| Mar2022 | ₹432 Cr | 13.96 | |
| Mar2021 | ₹379 Cr | - | |
Compare Total Non-Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹1,981.4 Cr | -2.9% | -18.2% | -60% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.9% |
-18.2% |
-60% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses